Onconetix, Inc. Finance Lease, Right-of-Use Asset, Amortization
Onconetix, Inc. (ONCO) reported Finance Lease, Right-of-Use Asset, Amortization of $49.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- Onconetix, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $0.00.
- Onconetix, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $49.00K, a 44.32% decline year-over-year.
- Onconetix, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $88.00K.
- Onconetix, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-12-31 was $0.00.
- Onconetix, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $49.00K, a 44.32% decline from fiscal 2024.
- Onconetix, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $88.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $49.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | $49.00K 10-K · filed 2026-03-13 | ||||
| 2025-03-31 | $88.00K 10-Q · filed 2025-06-12 | $88.00K derived: sum of 2 quarters · filed 2025-06-12 | $88.00K derived: sum of 3 quarters · filed 2025-06-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $0.00 derived: sum of 2 quarters · filed 2025-06-02 | $88.00K 10-K · filed 2025-06-02 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $88.00K 10-Q · filed 2024-12-10 | |||
| 2024-06-30 | $88.00K 10-Q · filed 2024-08-29 | ||||
| 2024-04-01 | $88.00K 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |